Systematic Literature Review of the Impact of Endocrine Monotherapy and in Combination with Targeted Therapy on Quality of Life of Postmenopausal Women with HR+/HER2 − Advanced Breast Cancer

ConclusionsET  + TT users experienced similar QoL in the first-line and ET-failure setting relative to patients on ET mono. Moreover, ET + TT users experienced better QoL outcomes in some domains in the ET-failure setting relative to ET mono users.FundingNovartis.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research